NDC | 50580-736-01 |
Set ID | 36513fd5-a7bd-40ef-b396-5f92e7ea0b2c |
Category | HUMAN OTC DRUG LABEL |
Packager | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division |
Generic Name | |
Product Class | alpha-1 Adrenergic Agonist |
Product Number | |
Application Number | PART341 |
- SPL UNCLASSIFIED SECTION
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- heart disease
- high blood pressure
- thyroid disease
- diabetes
- trouble urinating due to an enlarged prostate gland
- Directions
- Other information
-
Inactive ingredients
carnauba wax, D&C yellow no. 10 aluminum lake, FD&C red no. 40 aluminum lake, FD&C yellow no. 6 aluminum lake, magnesium stearate, microcrystalline cellulose, modified starch, polyethylene glycol, polyvinyl alcohol, powdered cellulose, pregelatinized starch, sodium starch glycolate, talc, titanium dioxide
- Questions or comments?
- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENT
-
Uses
- temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- sneezing
- itchy, watery eyes
- itching of the nose or throat
- nasal congestion
- temporarily relieves these symptoms due to the common cold:
- runny nose
- sneezing
- nasal congestion
- temporarily relieves sinus congestion and pressure
- temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
-
Warnings
Do not use
- to make a child sleepy
- with any other product containing diphenhydramine, even one used on skin
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- heart disease
- high blood pressure
- thyroid disease
- diabetes
- trouble urinating due to an enlarged prostate gland
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
When using this product
- do not exceed recommended dose
- marked drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
- excitability may occur, especially in children
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
-
PRINCIPAL DISPLAY PANEL
NDC 50580-736-01
SUDAFEDPE®
DAY+NIGHT SINUS CONGESTION
Phenylephrine HCl
Nasal DecongestantDAYTIME
NASAL CONGESTION
12 TABLETS, 10 mg EACH
actual
sizeDiphenhydramine HCl, Phenylephrine HCl
Antihistamine, Nasal DecongestantNIGHTTIME
NASAL CONGESTION
RUNNY NOSE
*small tablet size
8 ULTRATABS®* TABLETS
TOTAL: 20 TABLETS -
INGREDIENTS AND APPEARANCE
SUDAFED PE DAY PLUS NIGHT SINUS CONGESTION
diphenhydramine hydrochloride and phenylephrine hydrochloride kitProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:50580-736 Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50580-736-01 1 in 1 PACKAGE 06/26/2017 Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 2 BLISTER PACK 12 Part 2 2 BLISTER PACK 8 Part 1 of 2 SUDAFED PE CONGESTION
phenylephrine hydrochloride tabletProduct Information Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV) Phenylephrine Hydrochloride 10 mg Inactive Ingredients Ingredient Name Strength carnauba wax (UNII: R12CBM0EIZ) D&C yellow no. 10 (UNII: 35SW5USQ3G) aluminum oxide (UNII: LMI26O6933) FD&C red no. 40 (UNII: WZB9127XOA) FD&C yellow no. 6 (UNII: H77VEI93A8) magnesium stearate (UNII: 70097M6I30) microcrystalline cellulose (UNII: OP1R32D61U) polyethylene glycol, unspecified (UNII: 3WJQ0SDW1A) polyvinyl alcohol, unspecified (UNII: 532B59J990) powdered cellulose (UNII: SMD1X3XO9M) sodium starch glycolate type A potato (UNII: 5856J3G2A2) talc (UNII: 7SEV7J4R1U) titanium dioxide (UNII: 15FIX9V2JP) Product Characteristics Color RED Score no score Shape ROUND Size 7mm Flavor Imprint Code WL;80;PE Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 6 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 07/13/2015 Part 2 of 2 SUDAFED PE SINUS CONGESTION PLUS ALLERGY
diphenhydramine hydrochloride and phenylephrine hydrochloride tablet, film coatedProduct Information Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Diphenhydramine Hydrochloride (UNII: TC2D6JAD40) (Diphenhydramine - UNII:8GTS82S83M) Diphenhydramine Hydrochloride 25 mg Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV) Phenylephrine Hydrochloride 10 mg Inactive Ingredients Ingredient Name Strength carnauba wax (UNII: R12CBM0EIZ) FD&C blue no. 1 (UNII: H3R47K3TBD) aluminum oxide (UNII: LMI26O6933) magnesium stearate (UNII: 70097M6I30) microcrystalline cellulose (UNII: OP1R32D61U) polyethylene glycol, unspecified (UNII: 3WJQ0SDW1A) polyvinyl alcohol, unspecified (UNII: 532B59J990) powdered cellulose (UNII: SMD1X3XO9M) sodium starch glycolate type A potato (UNII: 5856J3G2A2) talc (UNII: 7SEV7J4R1U) titanium dioxide (UNII: 15FIX9V2JP) Product Characteristics Color BLUE Score no score Shape OVAL Size 13mm Flavor Imprint Code PE;WL95 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 4 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 06/26/2017 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 06/26/2017 Labeler - Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division (878046358)